Court grants bail to former Mumbai airport MD G V Sanjay Reddy in `money-laundering case outlookindia.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from outlookindia.com Daily Mail and Mail on Sunday newspapers.
DECCAN CHRONICLE.
Updated Jul 29, 2021, 7:41 am IST
The medicines used for Covid 19 management have been added in the National List of Essential Medicines to make it affordable to people
Devices like pulse oximeters, blood pressure monitoring machines, nebulizers, digital thermometers and glucometers from China and Korea have flooded the market. PTI
Hyderabad: Ceiling prices have been set for remdesivir injections, amphotericin, dexamethasone and oxygen concentrators by the National Pharmaceutical Pricing Authority but the implementation is the key for it to benefit the people.
The medicines used for Covid 19 management have been added in the National List of Essential Medicines to make it affordable to people. There are five enforcement officers for the state to implement the order of the NPPA.
Interview with Alex Nocifera, Field Day socaltech.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from socaltech.com Daily Mail and Mail on Sunday newspapers.
Beware! Vaccine will now burn a hole in your pocket
Beware! Vaccine will now burn a hole in your pocket
BySridhar VivanSridhar Vivan / Updated: May 28, 2021, 06:00 IST
State govt revises ‘
hospital fee’ for vaccination from Rs 100 to Rs 200 for pvt hospitals
If you are fretting over the fact that private hospitals are administering vaccines at higher prices, be prepared to spend some more bucks as the State Government on Thursday increased the conveyance fee from Rs 100 to Rs 200.
The Private Hospitals and Nursing Homes Association-Karnataka (PHANA) had earlier written to the Government, demanding a revised “hospital fee” for vaccination from the current Rs 100 to Rs 300. In the letter, PHANA president Dr HM Prasanna said, “In this phase, the private sector is purchasing the
Goldman Sachs invests in Aragen Life Sciences (GVK Bio)
May 20, 2021
The company has invested more than $3.6 billion in capital since 2006
Goldman Sachs has acquired a significant minority stake in Aragen Life Sciences (Aragen), formerly known as GVK Biosciences, by acquiring shares previously held by ChrysCapital and other existing shareholders.
Aragen is a leading provider of outsourced discovery, development, and manufacturing services across both large and small molecule platforms.
Promoted by GV Sanjay Reddy of the Hyderabad based GVK Group in 2001, it has become a specialised contract research organisation. In 2004, DS Brar of Ranbaxy became a co-promoter.
While the company did not disclose a deal value, the acquisition of 33 per cent stake is estimated to be about ₹2,400 crore with the company valued at ₹7,300 crore (about a billion dollars).